Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56

<p>Forbion celebrates its 20th anniversary this year, with a whopping €5 billion raised so far. Sander marks the occasion by discussing how Forbion plans to promote life sciences investments in Europe via the Life Sciences VC Coalition. We chat about building European biotech champions like Argenx, the thriving Chinese biotech space, and why life should be fun, not only dealflow. </p><p><br></p><p><br></p><p>---</p><p><br></p><p>This episode is brought to you by GeneNovate Investors Day, an invite-only event for scientists, startups, investors, and industry leaders working at the forefront of cell and gene therapies. Learn more: <a href="https://bit.ly/flot-genenovate" target="_blank" rel="ugc noopener noreferrer">https://bit.ly/flot-genenovate</a> or reach out to [nadja.pahl@bih-charite.de](<a href="mailto:nadja.pahl@bih-charite.de" target="_blank" rel="ugc noopener noreferrer">mailto:nadja.pahl@bih-charite.de</a>) </p><p><br></p><p>---</p><p><br></p><p><br></p><p>⭐️ ABOUT THE SPEAKER</p><p><br></p><p><br></p><p>Sander co-founded Forbion in 2006. Prior to co-founding Forbion, Sander co-founded ABN AMRO Capital/Life Sciences in 2000. Sander serves on the boards of NorthSea Therapeutics &amp; Azafaros, with previous board roles at NewAmsterdam Pharma, Replimune &amp; uniQure.</p><p><br></p><p><br></p><p>🔗 LINKS MENTIONED</p><p><br></p><p><br></p><ul><li>Forbion website — <a href="https://forbion.com/" target="_blank" rel="ugc noopener noreferrer">https://forbion.com/</a></li><li>Forbion Joins Newly Launched European Life Sciences Coalition — <a href="https://forbion.com/news-insights/news/forbion-joins-newly-launched-european-life-sciences-coalition/" target="_blank" rel="ugc noopener noreferrer">https://forbion.com/news-insights/news/forbion-joins-newly-launched-european-life-sciences-coalition/</a></li><li>Novartis acquires Gyroscope Therapeutics — <a href="https://www.novartis.com/news/media-releases/novartis-acquire-gyroscope-therapeutics-adding-one-time-gene-therapy-could-transform-care-geographic-atrophy-leading-cause-blindness" target="_blank" rel="ugc noopener noreferrer">https://www.novartis.com/news/media-releases/novartis-acquire-gyroscope-therapeutics-adding-one-time-gene-therapy-could-transform-care-geographic-atrophy-leading-cause-blindness</a></li><li>GSK acquires Aiolos Bio — <a href="https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-aiolos-bio/" target="_blank" rel="ugc noopener noreferrer">https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-aiolos-bio/</a></li><li>European Biotech Act — <a href="https://health.ec.europa.eu/publications/proposal-regulation-establish-measures-strengthen-unions-biotechnology-and-biomanufacturing-sectors_en" target="_blank" rel="ugc noopener noreferrer">https://health.ec.europa.eu/publications/proposal-regulation-establish-measures-strengthen-unions-biotechnology-and-biomanufacturing-sectors_en</a></li><li>Capital markets union — <a href="https://finance.ec.europa.eu/financial-markets/financial-markets-policy/capital-markets-union_en" target="_blank" rel="ugc noopener noreferrer">https://finance.ec.europa.eu/financial-markets/financial-markets-policy/capital-markets-union_en</a></li><li>Gimv discontinues activities for new Life Sciences investments — <a href="https://www.gimv.com/en/news/gimv-increases-focus-strategic-objectives-and-discontinues-activities-new-life-sciences" target="_blank" rel="ugc noopener noreferrer">https://www.gimv.com/en/news/gimv-increases-focus-strategic-objectives-and-discontinues-activities-new-life-sciences</a></li><li>Why the Strait of Hormuz matters so much in the Iran war — <a href="https://www.bbc.co.uk/news/articles/c78n6p09pzno" target="_blank" rel="ugc noopener noreferrer">https://www.bbc.co.uk/news/articles/c78n6p09pzno</a></li><li>Antoine Papiernik, Sofinnova | Billion Investing with Balance — <a href="https://flot.bio/episode/antoine-papiernik-sofinnova-ebillion-biotech-investing-with-ba